GEMCITABINE- CARBOPLATIN COMBINATION THERAPY FOR RECURRENT OVARIAN CANCER: A PROSPECTIVE STUDY

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MODARES GILANI M.; BEHTASH N.; KARIMI ZARCHI M.; SAMIZADEH Z.; GHAEM MAGHAMI FATEMEH; MOUSAVI A.A.S.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ) Year:2008 | Volume:66 | Issue:7 Page(s): 480-484

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

7,904

Download:

Cites:

Information Journal Paper

Title

GEMCITABINE- CARBOPLATIN COMBINATION THERAPY FOR RECURRENT OVARIAN CANCER: A PROSPECTIVE STUDY

Author(s)

Keywords

OVARIAN CANCERQ2

RECURRENCEQ3

GEMCITABINQ2

CARBOPLATINQ2

SURVIVALQ3

Abstract

Background: OVARIAN CANCER is the leading cause of death among all gynecologic cancers in developed countries. The standard treatment for advanced OVARIAN CANCER consists of cytoreductive surgery associated with a platinum/paclitaxel-based chemotherapy. Over than 50% of patients with advanced OVARIAN CANCER will develop recurrent disease. For those patients who have RECURRENCE of disease at least six months after initial therapy, the paclitaxel- platinum combination has been shown to be a superior treatment to platinum monotherapy. However, many patients develop clinically relevant neurotoxicity, frequently resulting in treatment discontinuation. The efficacy and safety of an alternative regimen that dose not show significant neurotoxicity were evaluated by comparing GEMCITABIN- CARBOPLATIN with CARBOPLATIN in platinum sensitive recurrent OVARIAN CANCER patients in a Gynecologic Cancer InterGroup trial in Canada and European Organization for research and treatment of Cancer Gynecological Cancer Group. But this study was not done in Iran.Methods: We performed a study with escalating doses of GEMCITABIN combined with CARBOPLATIN in 21 patients. All patients who were treated in Vali-Asr hospital between 2003- 2005 evaluated. GEMCITABIN with dose of 800mg/m2 was given on days 1, 8 and 15 followed by one week rest period for a 28 day cycle. Combine with CARBOPLATIN with AUC 4 given on day 2. All patients with surgically resected, histologically confirmed epithelial OVARIAN CANCER and who had failed first- line platinum chemotherapy were allocated to this study.Results: Median age was 49 years (range 23-78 years). Median follow-up was six months (range 4-22). Total of 87 cycles of chemotherapy were administered with median number of four (range 2-6 cycles). Thrombocytopenia (grade I) and leucopenia (grade I) were seen in 4.75% and 9.52% of patients.Conclusion: GEMCITABIN and CARBOPLATIN Combination was tolerated in patients with RECURRENCE of OVARIAN CANCER.

Cites

No record.

References

No record.

Cite

APA: Copy

MODARES GILANI, M., BEHTASH, N., KARIMI ZARCHI, M., SAMIZADEH, Z., GHAEM MAGHAMI, FATEMEH, & MOUSAVI, A.A.S.. (2008). GEMCITABINE- CARBOPLATIN COMBINATION THERAPY FOR RECURRENT OVARIAN CANCER: A PROSPECTIVE STUDY. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), 66(7), 480-484. SID. https://sid.ir/paper/39375/en

Vancouver: Copy

MODARES GILANI M., BEHTASH N., KARIMI ZARCHI M., SAMIZADEH Z., GHAEM MAGHAMI FATEMEH, MOUSAVI A.A.S.. GEMCITABINE- CARBOPLATIN COMBINATION THERAPY FOR RECURRENT OVARIAN CANCER: A PROSPECTIVE STUDY. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ)[Internet]. 2008;66(7):480-484. Available from: https://sid.ir/paper/39375/en

IEEE: Copy

M. MODARES GILANI, N. BEHTASH, M. KARIMI ZARCHI, Z. SAMIZADEH, FATEMEH GHAEM MAGHAMI, and A.A.S. MOUSAVI, “GEMCITABINE- CARBOPLATIN COMBINATION THERAPY FOR RECURRENT OVARIAN CANCER: A PROSPECTIVE STUDY,” TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), vol. 66, no. 7, pp. 480–484, 2008, [Online]. Available: https://sid.ir/paper/39375/en

Related Journal Papers